Skip Navigation

European Journal of Heart Failure 2003 5(6):759-765; doi:10.1016/S1388-9842(03)00156-9
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sabelis, L.W.E.
Right arrow Articles by Mosterd, W.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabelis, L.W.E.
Right arrow Articles by Mosterd, W.L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 European Society of Cardiology

Determinants of insulin sensitivity in chronic heart failure

L.W.E. Sabelisa,*, P.J. Sendenc, M.L. Zonderlanda, A. van de Wield, J.P.M. Wielderse, I.A. Huisvelda, T.W. van Haeftenb and W.L. Mosterda,c

a Department of Sports Medicine, University Medical Center Utrecht Utrecht, The Netherlands
b Department of Internal Medicine, University Medical Center Utrecht Utrecht, The Netherlands
c Department of Cardiology, Meander Medical Center Amersfoort, The Netherlands
d Department of Internal Medicine, Meander Medical Center Amersfoort, The Netherlands
e Department of Laboratory Medicine, Meander Medical Center Amersfoort, The Netherlands

* Corresponding author. Tel.: +31-30-253-8925; fax: +31-30-253-9036 E-mail address: l.w.esabelis{at}med.uu.nl


   Abstract

Objective: To describe the determinants of insulin sensitivity (IS) in chronic heart failure (CHF), we created a model in which the influence of lifestyle factors and etiology of heart failure on IS were incorporated concomitantly with age, left ventricular ejection fraction (LVEF) and parameters of body composition.

Design: Observational cohort study.

Setting: Outpatient clinic for chronic heart failure.

Patients: Fifty-seven male CHF patients [NYHA class II–III, age 61±9 years, body mass index (BMI) 26.9±3.3 kg/m2 (mean±S.D.)].

Interventions: Euglycemic hyperinsulinemic clamp, cycle ergometry, anthropometric measurements, LVEF and a physical activity questionnaire. Main outcome measures: A model explaining the variance of IS in CHF. Results: IS was 18.2±8.6 µg·kg–1·min–1·mU–1·l–1, fasting insulin level was 15.9±11.0 mU/l and fasting glucose level was 5.5±0.6 mmol/l. Peak Vo2 was 19.1±4.9 ml·kg–1·min–1 and LVEF 26.2±7.1%. IS was inversely associated with fasting insulin concentration (r=–0.50, P<0.001) and BMI (r=–0.54, P<0.001). After controlling for BMI, IS also revealed a correlation with age (r=–0.36, P<0.01). The model explained 60% of variance in IS: BMI contributed 20%, smoking 17%, age 17% and physical activity in daily life (DPA) 16% (all P<0.05) to the variance of IS, whereas LVEF (9%) and etiology of heart failure (8%) contributed moderately.

Conclusions: In CHF patients, IS is for a major part predicted by BMI, smoking, age, daily physical activity, LVEF and etiology of heart failure.

Key Words: Chronic heart failure • Insulin sensitivity • Exercise tolerance

Received April 2, 2003; Revised May 8, 2003; Accepted July 31, 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
G. Grassi, G. Bolla, F. Quarti-Trevano, F. Arenare, G. Brambilla, and G. Mancia
Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers
Eur J Heart Fail, December 1, 2008; 10(12): 1186 - 1191.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
R. C Parish and J. D Evans
Inflammation in Chronic Heart Failure
Ann. Pharmacother., July 1, 2008; 42(7): 1002 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. W. van Haeften, M. L. Zonderland, L. W.E. Sabelis, and J. van Doorn
IGF-Binding Protein-1 Levels Are Related to Insulin-Mediated Glucose Disposal and Are a Potential Serum Marker of Insulin Resistance: Response to Maddux et al.
Diabetes Care, June 1, 2007; 30(6): e53 - e53.
[Full Text] [PDF]


Home page
Diabetes CareHome page
B. A. Maddux, A. Chan, E. A. De Filippis, L. J. Mandarino, and I. D. Goldfine
IGF-Binding Protein-1 Levels Are Related to Insulin-Mediated Glucose Disposal and Are a Potential Serum Marker of Insulin Resistance: Response to van Haeften et al.
Diabetes Care, June 1, 2007; 30(6): e54 - e54.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.